Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_provenance.
- NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_assertion description "[In conclusion, this study suggests that the genetic variants of CASP7 and CASP9 in the apoptosis pathway may be important predictive markers for EA susceptibility and that PGR in the sex hormone signaling pathway may be associated with the gender differences in EA risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_provenance.
- NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_assertion evidence source_evidence_literature NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_provenance.
- NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_assertion SIO_000772 20453000 NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_provenance.
- NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_assertion wasDerivedFrom gad-20150221 NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_provenance.
- NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_assertion wasGeneratedBy ECO_0000203 NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_provenance.
- gad-20150221 importedOn "2015-02-21" NP175728.RAO_4QAXzUmtyJM0B903Z-XbXm8EgdOZuDtbsHL_VoyTM130_provenance.